Last reviewed · How we verify
NCT05873842: TRAFIC-PTA
TRAns-Femoral Access Intravascular Lithotripsy Comparison With PTA in TAVI
trial testing Trans-femoral TAVI in Trans-femoral TAVI With Calcified Ilio-femoral Arteries in 50 participants. Currently enrolling.
1 November 2026
Quick facts
| Lead sponsor | Rede Optimus Hospitalar SA |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 22 July 2024 |
| Primary completion | 1 November 2026 |
| Estimated completion | 1 November 2026 |
| Sites | 5 locations across Italy |
Drugs / interventions tested
- Trans-femoral TAVI
Conditions studied
- Trans-femoral TAVI With Calcified Ilio-femoral Arteries — all drugs for Trans-femoral TAVI With Calcified Ilio-femoral Arteries →
Sponsor
Rede Optimus Hospitalar SA
Who can join
18 and older, any sex, with Trans-femoral TAVI With Calcified Ilio-femoral Arteries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the effectiveness and the safety of femoral-iliac IVL versus balloon only PTA for successful deployment of transfemoral transcatheter aortic valve prosthesis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05873842
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rede Optimus Hospitalar SA trials
Trials by the same sponsor.
- NCT06898086 — Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI) · NA · recruiting
- NCT06332911 — Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair · recruiting
- NCT05625997 — Shockwave IVL + DCB · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05873842 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rede Optimus Hospitalar SA
- Last refreshed: 16 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05873842.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing